![](https://www.worldpharmaceuticals.net/wp-content/themes/goodlife-wp-B2B/images/WhitePaper_Default_icon.png)
Splendid similarities
By Medizone
The benefits of biosimilars have long been championed in the medical sector, but with their use set to increase in emerging economies, securing the ever-expanding cold chain becomes more important. Gerhard Hörl, managing director of Medizone, looks at how to mitigate the associated risks.
![](https://www.worldpharmaceuticals.net/wp-content/themes/goodlife-wp-B2B/images/WhitePaper_Default_icon.png)